Abstract:The incidence of human herpesvirus (HHVs) is gradually increasing and has affected a wide range of population. HHVs can result in serious consequences such as tumors, neonatal malformations, sexually transmitted diseases, as well as pose an immense threat to the human health. The cGAS-STING pathway is one of the innate immune pattern-recognition receptors discovered recently. This article discusses the role of the cGAS-STING pathway in human diseases, especially in human herpesvirus infections, as well as highlights how these viruses act on this pathway to evade the host immunity. Moreover, the author provides a comprehensive overview of modulators of the cGAS-STING pathway. By focusing on the small molecule compounds based on the cGAS-STING pathway, novel targets and concepts have been proposed for the development of antiviral drugs and vaccines, while also providing a reference for the investigation of disease models related to the cGAS-STING pathway. HHV is a double-stranded DNA virus that can trigger the activation of intracellular DNA sensor cGAS, after which the host cells initiate a cascade of reactions that culminate in the secretion of type I interferon to restrict the viral replication. Meanwhile, the viral protein can interact with various molecules in the cGAS-STING pathway. Viruses can evade immune surveillance and maintain their replication by inhibiting the enzyme activity of cGAS and reducing the phosphorylation levels of STING, TBK1 and IRF3 and suppressing the interferon gene activation. Activators and inhibitors of the cGAS-STING pathway have yielded numerous promising research findings in vitro and in vivo pertaining to cGAS/STING-related disease models. However, there remains a dearth of small molecule modulators that have been successfully translated into clinical applications, which serves as a hurdle to be overcome in the future.

Toll‐like Receptors As Novel Therapeutic Targets for Herpes Simplex Virus Infection

Toll-Like Receptors in Human Papillomavirus Infection

T Cell Receptor Signaling Pathways： New Targets for Herpes Simplex Virus

Receptors and ligands for herpes simplex viruses: Novel insights for drug targeting

Toward the Eradication of Herpes Simplex Virus: Vaccination and Beyond

HSV-2 Infection of Human Genital Epithelial Cells Upregulates TLR9 Expression Through the SP1/JNK Signaling Pathway

Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection

Targeting herpesvirus entry complex and fusogen glycoproteins with prophylactic and therapeutic agents

A review of HSV pathogenesis, vaccine development, and advanced applications

Role of Specific Innate Immune Responses in Herpes Simplex Virus Infection of the Central Nervous System.

Traditional Chinese Medicine As a Potential Source for HSV-1 Therapy by Acting on Virus or the Susceptibility of Host

Clinical management of herpes simplex virus infections: past, present, and future

Tissue-Resident-Memory CD8+ T Cells Bridge Innate Immune Responses in Neighboring Epithelial Cells to Control Human Genital Herpes

Modulation of Endosome Function, Vesicle Trafficking and Autophagy by Human Herpesviruses

The battle between the innate immune cGAS-STING signaling pathway and human herpesvirus infection

Role of Innate Interferon Responses at the Ocular Surface in Herpes Simplex Virus-1-Induced Herpetic Stromal Keratitis

Insights on the Cgas-Sting Signaling Pathway During Herpesvirus Infections

Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics

An updated review of HSV-1 infection-associated diseases and treatment, vaccine development, and vector therapy application

Silencing Herpes Simplex Virus Type 1 Capsid Protein Encoding Genes by Sirna: A Promising Antiviral Therapeutic Approach

A Subcellular Quantitative Proteomic Analysis of Herpes Simplex Virus Type 1-Infected HEK 293T Cells